Erratum

In the July 18 issue, a sentence in “From the President” was incorrectly edited. The affected area should have read, “[W]e set a limit of $10,000 a year of pharma income per participant [to be eligible to serve on the DSM-V Task Force or a work group]. Since we have had complaints that the limit is both too high and too low, we have probably done the best we could.” ▪